Sherif Hanafy Mahmoud
Sherif Hanafy Mahmoud
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta
Verified email at ualberta.ca - Homepage
Title
Cited by
Cited by
Year
Augmented renal clearance in critical illness: an important consideration in drug dosing
SH Mahmoud, C Shen
Pharmaceutics 9 (3), 36, 2017
352017
Effects of angiotensin II blockade on inflammation‐induced alterations of pharmacokinetics and pharmacodynamics of calcium channel blockers
S Hanafy, NJ Dagenais, WF Dryden, F Jamali
British journal of pharmacology 153 (1), 90-99, 2008
292008
Effect of inflammation on molecular targets and drug transporters
S Hanafy, AOS El-Kadi, F Jamali
Journal of Pharmacy & Pharmaceutical Sciences 15 (3), 361-375, 2012
252012
Inflammation alters angiotensin converting enzymes (ACE and ACE-2) balance in rat heart
S Hanafy, M Tavasoli, F Jamali
Inflammation 34 (6), 609-613, 2011
212011
Effect of obesity on response to cardiovascular drugs in pediatric patients with renal disease
S Hanafy, M Pinsk, F Jamali
Pediatric Nephrology 24 (4), 815-821, 2009
142009
Antiepileptic drug removal by continuous renal replacement therapy: a review of the literature
SH Mahmoud
Clinical drug investigation 37 (1), 7-23, 2017
132017
Therapeutic drug monitoring of levetiracetam in select populations
D Jarvie, SH Mahmoud
Journal of Pharmacy & Pharmaceutical Sciences 21 (1s), 149s-176s, 2018
112018
Systematic Review of Clobazam Use in Patients with Status Epilepticus
SH Mahmoud, C Rans
Epilepsia Open, 2018
72018
Seizures and choice of antiepileptic drugs following subarachnoid hemorrhage: a review
SH Mahmoud, J Buxton
Canadian Journal of Neurological Sciences 44 (6), 643-653, 2017
72017
Drug-disease interaction: reduced verapamil response in isoproterenol-induced myocardial injury in rats
S Hanafy, AO El-Kadi, F Jamali
Pharmacology 86 (4), 196-202, 2010
62010
Inflammatory pathways following subarachnoid hemorrhage
KMW Khey, A Huard, SH Mahmoud
Cellular and molecular neurobiology 40 (5), 675-693, 2020
32020
The Future of Neurocritical Care Research: Proceedings and Recommendations from the Fifth Neurocritical Care Research Network Conference
S Hocker, S Shah, P Vespa, JJ Provencio, E Calvillo, DM Olson, CPV Rao, ...
Neurocritical Care, 1-5, 2020
22020
Patient assessment in clinical pharmacy: a comprehensive guide
SH Mahmoud
Springer, 2019
22019
Risk of hyponatremia in patients with aneurysmal subarachnoid hemorrhage treated with exogenous vasopressin infusion
N Marr, J Yu, DJ Kutsogiannis, SH Mahmoud
Neurocritical care 26 (2), 182-190, 2017
22017
The Impact of Nimodipine Administration through Feeding Tube on Outcomes in Patients with Aneurysmal Subarachnoid Hemorrhage
FA Isse, YEH Abdallah, SH Mahmoud
Journal of Pharmacy & Pharmaceutical Sciences 23, 100-108, 2020
12020
Is Therapeutic Drug Monitoring of Lacosamide Needed in Patients with Seizures and Epilepsy?
L Schultz, SH Mahmoud
European Journal of Drug Metabolism and Pharmacokinetics, 1-35, 2020
12020
Critical Care Assessment
SH Mahmoud, C Yearwood
Patient Assessment in Clinical Pharmacy, 353-373, 2019
12019
Adjuvant arthritis influences expression of housekeeping genes
S Hanafy, F Jamali
Inflammation Research 60 (6), 521-523, 2011
12011
Nimodipine Pharmacokinetic Variability in Various Patient Populations
SH Mahmoud, X Ji, FA Isse
Drugs in R&D, 1-12, 2020
2020
Enantioselective assay of nimodipine in human plasma using liquid chromatography–tandem mass spectrometry
FA Isse, T Le, SH Mahmoud
Biomedical Chromatography, e4971, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–20